PE-conjugated Anti-CLEC4C (litifilimab biosimilar) mAb

PE-conjugated Anti-CLEC4C (litifilimab biosimilar) mAb
SKU
DMABME100155P-100
Packaging Unit
100 test
Manufacturer
DIMA Biotechnology

Availability: loading...
Price is loading...
Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Description: PE-conjugated Anti-CLEC4C (litifilimab biosimilar) mAb

Storage & Shipping: Store at 2°C-8°C fo 6 months

Formulation & Reconstitution: Liquid,PBS with 0.05% Proclin300, 326% BSA

Target: CLEC4C

Uniprot ID: Q8WTT0

Usage: Research use only

Recommended Dilutions: Flow Cyt 1:100

Common Name: BIIB 059, BIIB-059, BIIB059

Guarantee: 6 months from date of dispatch
More Information
SKU DMABME100155P-100
Manufacturer DIMA Biotechnology
Manufacturer SKU BME100155P-100
Package Unit 100 test
Quantity Unit STK
Reactivity Human
Application Flow Cytometry
Isotype IgG1(E239D, M241L)
Host Human
Conjugate Conjugated, PE (Phycoerythrin)
Product information (PDF) Download
MSDS (PDF) Download